ARS won a Phase III clinical research project in 80 patients with degenerative brain diseases.

This will be a full-service contract, including clinical trial regulatory approval, project management, clinical monitoring, site and financial administration, biostatistics and data management, final clinical study report preparation, and drug marketing authorization. The European company will sponsor the clinical study in Russia.